Europe Patient-Controlled Analgesic Pumps Market By Type (Electronic and Mechanical), By Application (Oncology, Diabetes, Hematology, Gastroenterology and Others), By End-use (Hospitals, Specialty Clinics and Ambulatory Surgical Centers), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Patient-Controlled Analgesic Pumps Market
Market Report Description
The Europe Patient-controlled Analgesic Pumps Market would witness market growth of 9.2% CAGR during the forecast period (2021-2027). A high-performance single-chip microcomputer and control circuit are used by electronically patient-controlled analgesic pumps with an aim to efficiently control the infusion flow rate.
The demand of the segment is boosted due to the fact that electronic analgesic pumps are efficient and safe for patient-controlled epidural analgesia (PCEA) for children and post-operative pain management. In addition to it, recent researches have displayed that a huge portion of the population can use electronic PCA pumps as they are appropriate for them and can be regulated on the basis of the requirements of the patients. Though, electronic PCA pumps have the probability to show various PCA treatment errors. The growth of the segment would be hindered by the human and equipment errors that may happen at the time of the dosing phase.
Technological developments; supportive reimbursement policies; growing cases of chronic illnesses like pain, diabetes, and cancer; scope for infusion of multiple medications simultaneously; upgraded safety features; and portability of the system are catalysts that would provide momentum to the growth of the global PCA market to expand further. However, patient medication errors with infusion pumps resulting in product recalls are the key barriers for the growth of the global PCA market. Moreover, the global PCA market would further be hampered by the low amount of awareness regarding the modern infusion systems and stringent norms imposed on the approval of a product.
The Germany market dominated the Europe Hematology Market by Country in 2020, thereby, achieving a market value of $8,365.9 Thousands by 2027. The UK market is expected to witness a CAGR of 9% during (2021 - 2027). Additionally, The France market is poised to witness a CAGR of 11.4% during (2021 - 2027).
Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Specialty Clinics
- Ambulatory Surgical Centers
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Smiths Group PLC
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
- Baxter International, Inc.
- Becton, Dickinson and Company
- Terumo Corporation
- Abbott Laboratories
- Avante Health Solutions
- ICU Medical, Inc.
- Ace Medical Co., Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free